Max Robotics — Global Service Robot Directory + US Certification

About

Keith D. Lillemoe is a world-renowned pancreatic surgeon and researcher whose work has fundamentally shaped the modern management of pancreatic diseases. His primary research areas focus on the surgical treatment of pancreatic cancer, the optimization of minimally invasive pancreatic surgery, and the development of evidence-based guidelines to improve patient outcomes. A major contribution is his leadership in establishing expert consensus guidelines for managing the pancreatic transection plane after distal pancreatectomy, a critical step that reduces postoperative complications. He has also been a driving force in advancing robotic and laparoscopic pancreatic surgery, notably authoring a landmark 2010 study on the cost-effectiveness of robotic distal pancreatectomy (233 citations). More recently, his 2024 work on a complexity and experience grading system for minimally invasive pancreatoduodenectomy aims to safely guide patient selection and global adoption of these advanced techniques. With over 500 peer-reviewed publications and a career dedicated to improving outcomes for patients with pancreatic adenocarcinoma, Lillemoe’s impact is measured not only in thousands of citations but in the safer, more effective surgical care delivered worldwide.